comparemela.com

Latest Breaking News On - Insider activity at centessa pharmaceuticals - Page 1 : comparemela.com

Centessa Pharmaceuticals plc (NASDAQ:CNTA) Given Consensus Recommendation of "Moderate Buy" by Brokerages

Centessa Pharmaceuticals plc (NASDAQ:CNTA – Get Free Report) has been given a consensus rating of “Moderate Buy” by the seven research firms that are covering the stock, MarketBeat Ratings reports. Two investment analysts have rated the stock with a hold recommendation and five have issued a buy recommendation on the company. The average 12 month […]

Karenm-anderson
Td-asset-management-inc
Nasdaq
Centessa-pharmaceuticals
Institutional-trading-of-centessa-pharmaceuticals
Insider-activity-at-centessa-pharmaceuticals
Centessa-pharmaceuticals-stock-performance
Analyst-recommendations-for-centessa-pharmaceuticals
News-ratings-for-centessa-pharmaceuticals-daily
Acuta-capital-partners
Affinity-asset-advisors

Centessa Pharmaceuticals plc (NASDAQ:CNTA) Receives Average Recommendation of "Moderate Buy" from Brokerages

Shares of Centessa Pharmaceuticals plc (NASDAQ:CNTA – Get Free Report) have been given an average rating of “Moderate Buy” by the seven brokerages that are currently covering the company, MarketBeat.com reports. Two research analysts have rated the stock with a hold recommendation and five have issued a buy recommendation on the company. The average 12 […]

China
Karenm-anderson
China-universal-asset-management-co
Analyst-recommendations-for-centessa-pharmaceuticals
Securities-exchange-commission
Insider-activity-at-centessa-pharmaceuticals
Nasdaq
Affinity-asset-advisors
News-ratings-for-centessa-pharmaceuticals-daily
Acuta-capital-partners
Centessa-pharmaceuticals-trading

Centessa Pharmaceuticals (NASDAQ:CNTA) Shares Down 4%

Centessa Pharmaceuticals plc (NASDAQ:CNTA – Get Free Report)’s stock price dropped 4% on Monday . The company traded as low as $10.47 and last traded at $10.59. Approximately 8,254 shares traded hands during trading, a decline of 98% from the average daily volume of 448,759 shares. The stock had previously closed at $11.03. Analyst Ratings […]

China
Harris-rotman
Institutional-investors-weigh-in-on-centessa-pharmaceuticals
Barclays-plc
Nasdaq
Susquehanna-international-group
Centessa-pharmaceuticals
Insider-activity-at-centessa-pharmaceuticals
Jefferies-financial-group
Securities-exchange-commission
Centessa-pharmaceuticals-stock-down
Jpmorgan-chase-co

Centessa Pharmaceuticals (NASDAQ:CNTA) Stock Price Down 7.1%

Shares of Centessa Pharmaceuticals plc (NASDAQ:CNTA – Get Free Report) were down 7.1% during trading on Thursday . The stock traded as low as $6.51 and last traded at $6.51. Approximately 5,873 shares changed hands during trading, a decline of 96% from the average daily volume of 151,874 shares. The stock had previously closed at […]

Harris-rotman
Jpmorgan-chase-co
Institutional-trading-of-centessa-pharmaceuticals
Insider-activity-at-centessa-pharmaceuticals
Goldman-sachs-group
Prelude-capital-management
Nasdaq
News-ratings-for-centessa-pharmaceuticals-daily
Centessa-pharmaceuticals-company-profile
Centessa-pharmaceuticals
Centessa-pharmaceuticals-stock
Get-free-report

Centessa Pharmaceuticals plc (NASDAQ:CNTA) Given Average Rating of "Moderate Buy" by Brokerages

Shares of Centessa Pharmaceuticals plc (NASDAQ:CNTA – Get Free Report) have received an average rating of “Moderate Buy” from the seven brokerages that are currently covering the company, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation, one has assigned a hold recommendation and five have issued a buy […]

Harris-rotman
Insider-activity-at-centessa-pharmaceuticals
Nasdaq
Blackrock-inc
Analyst-recommendations-for-centessa-pharmaceuticals
Barclays-plc
Jpmorgan-chase-co
Centessa-pharmaceuticals
Goldman-sachs-group
News-ratings-for-centessa-pharmaceuticals-daily
Centessa-pharmaceuticals-trading
Geode-capital-management

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.